RESUMEN
No disponible
Asunto(s)
Humanos , Cirrosis Hepática/fisiopatología , Biopsia/métodos , Hepatitis C Crónica/complicaciones , Progresión de la Enfermedad , Hígado Graso/epidemiología , Biomarcadores/análisisRESUMEN
No disponible
No disponible
Asunto(s)
Femenino , Humanos , Masculino , Terapéutica/mortalidad , Terapéutica/enfermería , Hepatitis C Crónica/sangre , Hepatitis C Crónica/transmisión , Carcinoma Hepatocelular/congénito , Carcinoma Hepatocelular/patología , Preparaciones Farmacéuticas/administración & dosificación , Terapéutica/instrumentación , Terapéutica/métodos , Hepatitis C Crónica/metabolismo , Hepatitis C Crónica/patología , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/diagnóstico , Preparaciones FarmacéuticasRESUMEN
Nodular regenerative hyperplasia (NRH) of the liver is an infrequent entity that is usually diagnosed after the appearance of clinical signs of portal hypertension such as hepatomegaly, splenomegaly or upper gastrointestinal bleeding due to esophageal varices, which are the most frequently found clinical manifestations in NRH. Ascites is a less frequent finding and has always been described in association with other manifestations of portal hypertension. We describe a new case of NRH with atypical presentation in which ascites was the sole clinical manifestation.
Asunto(s)
Ascitis/etiología , Hiperplasia Nodular Focal/diagnóstico , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bronconeumonía/complicaciones , Terapia Combinada , Progresión de la Enfermedad , Resultado Fatal , Hiperplasia Nodular Focal/etiología , Hiperplasia Nodular Focal/patología , Humanos , Hipertensión Portal/etiología , Regeneración Hepática , Vértebras Lumbares , Masculino , Melfalán/administración & dosificación , Melfalán/efectos adversos , Mieloma Múltiple/complicaciones , Mieloma Múltiple/tratamiento farmacológico , Plasmacitoma/complicaciones , Plasmacitoma/tratamiento farmacológico , Plasmacitoma/radioterapia , Prednisona/efectos adversos , Neoplasias de la Columna Vertebral/complicaciones , Neoplasias de la Columna Vertebral/tratamiento farmacológico , Neoplasias de la Columna Vertebral/radioterapiaRESUMEN
We show the results of a retrospective study carried out during ten years (1978-1987), in Catalonia in the provinces of Barcelona and Gerona. The aim of the study was to evaluate the incidence and prevalence of inflammatory chronic bowel disease in our country, its clinical aspects, management and long term survival. An epidemiological inquiry was sent to all the hospitals and gastroenterologists of Catalonia. Nine hundred and seventy six answers were received from 20 Hospitals and four specialists. All of them were revised by the Research Committee, and 761 were validated for their inclusion in the study. The prevalence of the disease was similar both in Barcelona (19 per 100,000) and Gerona (18 per 100,000). The incidence of ulcerative colitis increased during the study, from 0.4 in 1978 to 0.8 in 1987, with a peak of maximum incidence (1.0 per 100,000) in 1985. In the same way, an increase in the incidence of Crohn's disease from 0.2 to 0.7 per 100,000, was observed. The mean incidence per year was 0.6 and 0.4 respectively, similar to the incidence observed in other Spanish regions during the same period of time. Finally we show the most important clinical and therapeutic aspects as well as the survival data.